Femasys Inc
FEMY0.508USD
+0.023+4.74%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
24.03M시가총액
손실P/E TTM
자세한 내용은 Femasys Inc 회사
Femasys Inc. is a biomedical company. The Company is focused on addressing the unmet needs of women worldwide with a broad portfolio of in-office, accessible, and therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable blended biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. It also developed FemCerv, which is an endocervical tissue sampler for cervical cancer diagnosis; FemVue, which is a companion diagnostic for fallopian tube assessment; FemCath, which is an intrauterine catheter, and FemChec.
Femasys Inc 정보
종목 코드 FEMY
회사 이름Femasys Inc
상장일Jun 18, 2021
CEOLee-Sepsick (Kathy)
직원 수69
유형Ordinary Share
회계 연도 종료Jun 18
주소3950 Johns Creek Court
도시SUWANEE
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호30024
전화17705003910
웹사이트https://www.femasys.com/
종목 코드 FEMY
상장일Jun 18, 2021
CEOLee-Sepsick (Kathy)
Femasys Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Ms. Kathy Lee-Sepsick
Ms. Kathy Lee-Sepsick
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
432.85K
+48535.00%
Mr. Alistair Milnes
Mr. Alistair Milnes
Independent Director
Independent Director
5.67K
--
Ms. Kelley Nicholas
Ms. Kelley Nicholas
Chief Commercial Officer
Chief Commercial Officer
80.00
+80.00%
Mr. Daniel Currie
Mr. Daniel Currie
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Charles E. Larsen
Mr. Charles E. Larsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Edward Uzialko, Jr.
Mr. Edward Uzialko, Jr.
Independent Director
Independent Director
--
--
Mr. Dov Elefant
Mr. Dov Elefant
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Christine Thomas
Ms. Christine Thomas
Chief Regulatory and Clinical Officer
Chief Regulatory and Clinical Officer
--
--
Mr. Joshua N. (Josh) Silverman
Mr. Joshua N. (Josh) Silverman
Independent Director
Independent Director
--
--
Dr. James Liu, M.D.
Dr. James Liu, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
이름
이름/직위
직위
주식 보유
변동
Ms. Kathy Lee-Sepsick
Ms. Kathy Lee-Sepsick
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
432.85K
+48535.00%
Mr. Alistair Milnes
Mr. Alistair Milnes
Independent Director
Independent Director
5.67K
--
Ms. Kelley Nicholas
Ms. Kelley Nicholas
Chief Commercial Officer
Chief Commercial Officer
80.00
+80.00%
Mr. Daniel Currie
Mr. Daniel Currie
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Charles E. Larsen
Mr. Charles E. Larsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Edward Uzialko, Jr.
Mr. Edward Uzialko, Jr.
Independent Director
Independent Director
--
--
수익 분석
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
기업이 아직 관련 데이터를 공개하지 않았습니다.
지역별USD
이름
수익
비율
United States
0.00
0.00%
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: 2 hours ago
마지막 업데이트: 2 hours ago
주주
주주 유형
주주
주주
비율
Chernett (Jorey)
5.19%
Dauntless Investment Group, LLC
2.96%
The Vanguard Group, Inc.
2.42%
Uzialko (Edward R Jr.)
2.08%
Alumni Capital Management LLC
1.59%
기타
85.75%
주주
주주
비율
Chernett (Jorey)
5.19%
Dauntless Investment Group, LLC
2.96%
The Vanguard Group, Inc.
2.42%
Uzialko (Edward R Jr.)
2.08%
Alumni Capital Management LLC
1.59%
기타
85.75%
주주 유형
주주
비율
Individual Investor
8.41%
Investment Advisor
6.49%
Investment Advisor/Hedge Fund
2.29%
Venture Capital
0.08%
Research Firm
0.04%
Bank and Trust
0.03%
Hedge Fund
0.03%
기타
82.63%
기관 주식 보유
마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
53
6.06M
9.41%
--
2025Q3
60
6.06M
10.92%
+931.90K
2025Q2
65
5.13M
15.23%
+1.22M
2025Q1
62
3.90M
17.97%
-962.46K
2024Q4
57
2.39M
11.54%
+713.58K
2024Q3
55
1.67M
11.99%
+32.62K
2024Q2
57
1.64M
11.51%
+117.87K
2024Q1
57
1.52M
11.83%
-1.09M
2023Q4
56
1.43M
10.18%
-232.64K
2023Q3
51
1.66M
10.47%
+405.22K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Chernett (Jorey)
3.03M
5.19%
+1.41M
+86.81%
Jun 30, 2025
Dauntless Investment Group, LLC
1.73M
2.96%
-588.24K
-25.35%
Sep 30, 2025
The Vanguard Group, Inc.
951.87K
1.63%
--
--
Sep 30, 2025
Uzialko (Edward R Jr.)
1.22M
2.08%
--
--
Apr 08, 2025
Alumni Capital Management LLC
931.90K
1.59%
+931.90K
--
Sep 04, 2025
Lee-Sepsick (Kathy)
432.85K
0.74%
+48.53K
+12.63%
Aug 27, 2025
Geode Capital Management, L.L.C.
258.23K
0.44%
+6.83K
+2.72%
Sep 30, 2025
Clear Creek Financial Management, LLC
138.90K
0.24%
-142.92K
-50.71%
Sep 30, 2025
Currie (Daniel Scott)
109.24K
0.19%
+19.61K
+21.88%
Jun 02, 2025
BlackRock Institutional Trust Company, N.A.
94.06K
0.16%
+1.66K
+1.79%
Sep 30, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
